Literature DB >> 2706647

Cardiovascular mortality in patients with rheumatoid arthritis.

O Mutru1, M Laakso, H Isomäki, K Koota.   

Abstract

Patients with rheumatoid arthritis (RA), 500 men and 500 women, aged 40 years and over, together with a control population matched by age and sex were followed up with respect to cause-specific mortality over a 10-year period. The overall mortality was significantly higher in both men and women with RA than in the controls. A statistically significant increase in mortality from all cardiovascular diseases (p less than 0.001) and cardiac diseases (p = 0.004) was observed in men with RA but not in women with RA compared to corresponding controls. No difference in mortality from cerebrovascular diseases was observed between RA patients and controls.

Entities:  

Mesh:

Year:  1989        PMID: 2706647     DOI: 10.1159/000174474

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  37 in total

1.  Inflammation-mediated rheumatic diseases and atherosclerosis.

Authors:  S Manzi; M C Wasko
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

2.  Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis.

Authors:  Cecilia P Chung; Jon T Giles; Michelle Petri; Moyses Szklo; Wendy Post; Roger S Blumenthal; Allan C Gelber; Pamela Ouyang; Nancy S Jenny; Joan M Bathon
Journal:  Semin Arthritis Rheum       Date:  2012-02       Impact factor: 5.532

3.  IgM colocalises with complement and C reactive protein in infarcted human myocardium.

Authors:  P A J Krijnen; C Ciurana; T Cramer; T Hazes; C J L M Meijer; C A Visser; H W M Niessen; C E Hack
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

4.  A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumatoid arthritis.

Authors:  Rachana Mishra; Aastha Singh; Vishal Chandra; Mahendra P S Negi; Baishnab C Tripathy; Jaya Prakash; Varsha Gupta
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

Review 5.  An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.

Authors:  Nick J Bansback; Dean A Regier; Roberta Ara; Alan Brennan; Kamran Shojania; John M Esdaile; Aslam H Anis; Carlo A Marra
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Authors:  Maria I Danila; Nivedita M Patkar; Jeffrey R Curtis; Kenneth G Saag; Gim Gee Teng
Journal:  Curr Opin Rheumatol       Date:  2008-05       Impact factor: 5.006

7.  Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis.

Authors:  Laura Bazzichi; Lorenzo Ghiadoni; Alessandra Rossi; Melania Bernardini; Mario Lanza; Francesca De Feo; Camillo Giacomelli; Ilaria Mencaroni; Katia Raimo; Marco Rossi; Anna Maria Mazzone; Stefano Taddei; Stefano Bombardieri
Journal:  Mol Med       Date:  2009-06-18       Impact factor: 6.354

Review 8.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

9.  [Multimorbidity in elderly rheumatic patients part 2].

Authors:  H-J Lakomek; T Brabant; M Lakomek; D Lüttje
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

10.  Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis.

Authors:  G Herrero-Beaumont; M E Marcos; O Sánchez-Pernaute; R Granados; L Ortega; E Montell; J Vergés; J Egido; R Largo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.